Education
About Us
Working with TipRanks
Follow Us
Kuros Biosciences Ltd. (CSBTF)
OTHER OTC:CSBTF
CSBTF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.30 - $36.10
Previous CloseN/A
Volume4.47K
Average Volume (3M)289.00
Market Cap
$776.59M
Enterprise Value$430.56M
Total Cash (Recent Filing)CHF20.80M
Total Debt (Recent Filing)CHF2.39M
Price to Earnings (P/E)―
Beta-0.16
Next Earnings
Mar 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding37,960,377
10 Day Avg. Volume157
30 Day Avg. Volume289
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Kuros Biosciences News
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
― Other Institutional Investors
98.84% Public Companies and
Individual Investors
CSBTF FAQ
What was Kuros Biosciences Ltd.’s price range in the past 12 months?
Kuros Biosciences Ltd. lowest stock price was $5.30 and its highest was $36.10 in the past 12 months.
What is Kuros Biosciences Ltd.’s market cap?
Kuros Biosciences Ltd.’s market cap is $776.59M.
When is Kuros Biosciences Ltd.’s upcoming earnings report date?
Kuros Biosciences Ltd.’s upcoming earnings report date is Mar 12, 2025 which is today.
How were Kuros Biosciences Ltd.’s earnings last quarter?
Kuros Biosciences Ltd. released its earnings results on Aug 08, 2024. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.007.
Is Kuros Biosciences Ltd. overvalued?
According to Wall Street analysts Kuros Biosciences Ltd.’s price is currently Overvalued.
Does Kuros Biosciences Ltd. pay dividends?
Kuros Biosciences Ltd. does not currently pay dividends.
What is Kuros Biosciences Ltd.’s EPS estimate?
Kuros Biosciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kuros Biosciences Ltd. have?
Kuros Biosciences Ltd. has 37,960,377 shares outstanding.
What happened to Kuros Biosciences Ltd.’s price movement after its last earnings report?
Kuros Biosciences Ltd. reported an EPS of -$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.2%.
Which hedge fund is a major shareholder of Kuros Biosciences Ltd.?
Currently, no hedge funds are holding shares in CSBTF
---
Company Description
Kuros Biosciences Ltd.
Kuros Biosciences Ltd is a biotechnology company that focuses on the discovery, development and prospective commercialization of a new class of bio-pharmaceutical products for use in the treatment and prevention of chronic diseases. The company is also developing a family of bone healing products to address indications in trauma, and spine as well as sealants which provides reliable closure of tissue membranes to ensure functional integrity after surgery or trauma. The pipeline products of the company are Synthetic Orthobiologics, Fibrin Orthobiologics, and Sealants. The majority of the company's revenue comes from the United States.
---
Technical Analysis
BioNano Genomics
―
Advaxis
―
Cyclacel Pharmaceuticals
―
Puma Biotechnology
―
Sarepta Therapeutics
―
Vertex Pharmaceuticals
―
---